Welldoc is a healthcare technology company that offers an AI-driven platform designed to deliver personalized, actionable insights for individuals managing chronic health conditions. The platform includes solutions for multiple conditions including Type 1 and Type 2 diabetes, hypertension, heart failure, weight management, prediabetes, and mental wellbeing. Welldoc’s flagship product, BlueStar, is FDA-cleared and supports the self-management of diabetes through digital coaching and connectivity to over 400 devices. The company aims to optimize healthcare interventions, improve population health, and reduce healthcare costs, working with health plans, systems, and employers.